These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36314943)

  • 1. Impact of Sex and Age on mRNA COVID-19 Vaccine-Related Side Effects in Japan.
    Mori M; Yokoyama A; Shichida A; Sasuga K; Maekawa T; Moriyama T
    Microbiol Spectr; 2022 Dec; 10(6):e0130922. PubMed ID: 36314943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of sex and age on vaccine-related side effects and their progression after booster mRNA COVID-19 vaccine.
    Mori M; Yokoyama A; Shichida A; Sasuga K; Maekawa T; Moriyama T
    Sci Rep; 2023 Nov; 13(1):19328. PubMed ID: 37935801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse reactions to the BNT162b2 and mRNA-1273 mRNA COVID-19 vaccines in Japan.
    Kitagawa H; Kaiki Y; Sugiyama A; Nagashima S; Kurisu A; Nomura T; Omori K; Akita T; Shigemoto N; Tanaka J; Ohge H
    J Infect Chemother; 2022 Apr; 28(4):576-581. PubMed ID: 35058126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse events of a third dose of BNT162b2 mRNA COVID-19 vaccine among Korean healthcare workers.
    Lee DY; Kang DY; Kim E; Lee SJ; Baek JH; Lee JS; Park MY; Im JH
    Medicine (Baltimore); 2023 Mar; 102(11):e33236. PubMed ID: 36930126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Side effects of Pfizer/BioNTech (BNT162b2) COVID-19 vaccine reported by the Birzeit University community.
    Abukhalil AD; Shatat SS; Abushehadeh RR; Al-Shami N; Naseef HA; Rabba A
    BMC Infect Dis; 2023 Jan; 23(1):5. PubMed ID: 36604613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of age, sex and medical history on adverse reactions to the first and second dose of BNT162b2 mRNA COVID-19 vaccine in Japan: a cross-sectional study.
    Urakawa R; Isomura ET; Matsunaga K; Kubota K; Ike M
    BMC Infect Dis; 2022 Feb; 22(1):179. PubMed ID: 35197017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of Immunogenicity and Reactogenicity of BNT162b2 and CoronaVac SARS-CoV-2 Vaccines.
    Zhang R; Leung KY; Liu D; Fan Y; Lu L; Chan PC; To KK; Chen H; Yuen KY; Chan KH; Hung IF
    mSphere; 2022 Apr; 7(2):e0091521. PubMed ID: 35285250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Young age, female sex, and presence of systemic adverse reactions are associated with high post-vaccination antibody titer after two doses of BNT162b2 mRNA SARS-CoV-2 vaccination: An observational study of 646 Japanese healthcare workers and university staff.
    Uwamino Y; Kurafuji T; Sato Y; Tomita Y; Shibata A; Tanabe A; Yatabe Y; Noguchi M; Arai T; Ohno A; Yokota H; Yamasawa W; Uno S; Nishimura T; Hasegawa N; Saya H; Wakui M; Murata M;
    Vaccine; 2022 Feb; 40(7):1019-1025. PubMed ID: 35033389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An observational study of adverse drug reactions to COVID-19 vaccines reported to the New Mexico poison center hotline.
    Tadfor Y; Nguyen-Hua N; Bennett H; Bos AJ; Smolinske SC
    Clin Toxicol (Phila); 2023 Jan; 61(1):77-83. PubMed ID: 36458888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse reactions to the first and second doses of Pfizer-BioNTech COVID-19 vaccine among healthcare workers.
    Maruyama A; Sawa T; Teramukai S; Katoh N
    J Infect Chemother; 2022 Jul; 28(7):934-942. PubMed ID: 35361536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerance for three commonly administered COVID-19 vaccines by healthcare professionals.
    Melanson SEF; Zhao Z; Kumanovics A; Love T; Meng QH; Wu AHB; Apple F; Ondracek CR; Schulz KM; Wiencek JR; Koch D; Christenson R; Zhang YV
    Front Public Health; 2022; 10():975781. PubMed ID: 36238255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and tolerability of the novel 2019 coronavirus disease (COVID-19) vaccines among people with epilepsy (PwE): A cross-sectional study.
    Massoud F; Ahmad SF; Hassan AM; Alexander KJ; Al-Hashel J; Arabi M
    Seizure; 2021 Nov; 92():2-9. PubMed ID: 34391030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse Reactions of the Second Dose of the BNT162b2 mRNA COVID-19 Vaccine in Healthcare Workers in Korea.
    Lee YW; Lim SY; Lee JH; Lim JS; Kim M; Kwon S; Joo J; Kwak SH; Kim EO; Jung J; Kwon HS; Kim TB; Kim SH; Bae S
    J Korean Med Sci; 2021 May; 36(21):e153. PubMed ID: 34060261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study.
    Menni C; May A; Polidori L; Louca P; Wolf J; Capdevila J; Hu C; Ourselin S; Steves CJ; Valdes AM; Spector TD
    Lancet Infect Dis; 2022 Jul; 22(7):1002-1010. PubMed ID: 35405090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse events after administration of the first and second doses of messenger RNA-based COVID-19 vaccines in Japanese subjects aged 12-18 years.
    Ogawa T; Yamada T; Matsumoto Y; Minami K; Kawanishi F; Nakano T; Ukimura A
    J Int Med Res; 2022 Oct; 50(10):3000605221127518. PubMed ID: 36217268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Side effects after COVID-19 vaccinations among residents of Poland.
    Andrzejczak-Grządko S; Czudy Z; Donderska M
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(12):4418-4421. PubMed ID: 34227078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between the BNT162b2 Messenger RNA COVID-19 Vaccine and the Risk of Sudden Sensorineural Hearing Loss.
    Yanir Y; Doweck I; Shibli R; Najjar-Debbiny R; Saliba W
    JAMA Otolaryngol Head Neck Surg; 2022 Apr; 148(4):299-306. PubMed ID: 35201275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of adverse effects and antibody responses following homologous and heterologous COVID19 prime-boost vaccinations.
    Cheng A; Hsieh MJ; Chang SY; Ieong SM; Cheng CY; Sheng WH; Chang SC
    J Formos Med Assoc; 2023 May; 122(5):384-392. PubMed ID: 36564299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance of Side Effects after Two Doses of COVID-19 Vaccines among Patients with Comorbid Conditions: A Sub-Cohort Analysis from Saudi Arabia.
    Mallhi TH; Khan YH; Butt MH; Salman M; Tanveer N; Alotaibi NH; Alzarea AI; Alanazi AS
    Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study.
    Massari M; Spila Alegiani S; Morciano C; Spuri M; Marchione P; Felicetti P; Belleudi V; Poggi FR; Lazzeretti M; Ercolanoni M; Clagnan E; Bovo E; Trifirò G; Moretti U; Monaco G; Leoni O; Da Cas R; Petronzelli F; Tartaglia L; Mores N; Zanoni G; Rossi P; Samez S; Zappetti C; Marra AR; Menniti Ippolito F;
    PLoS Med; 2022 Jul; 19(7):e1004056. PubMed ID: 35900992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.